Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...

書誌詳細
主要な著者:	Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D
フォーマット:	Conference item
出版事項:	Mary Ann Liebert Inc 2016

類似資料

Development of lung and muscle factories to deliver therapeutic monoclonal antibodies
著者:: Antepowicz, A
出版事項: (2018)

431. Lung antibody factory for passive immunisation against influenza
著者:: Tan, T, 等
出版事項: (2016)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
著者:: Du, Y, 等
出版事項: (2020)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
著者:: Antepowicz, A, 等
出版事項: (2018)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
著者:: Paul-Smith, M, 等
出版事項: (2017)

Development of monoclonal antibody therapeutics for alzheimer's disease
著者:: Masatoshi Takeda
出版事項: (2022-01-01)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
著者:: Paul-Smith, M, 等
出版事項: (2018)

Monoclonal Antibodies as Neurological Therapeutics
著者:: Panagiotis Gklinos, 等
出版事項: (2021-01-01)

Therapeutic monoclonal antibody for Sporotrichosis
著者:: Sandro eAlmeida
出版事項: (2012-11-01)

The development of gene therapy for diseases of the lung.
著者:: Gill, DR, 等
出版事項: (2004)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
著者:: Leonardo F. Ormundo, 等
出版事項: (2023-10-01)

Advances and challenges in therapeutic monoclonal antibodies drug development
著者:: Mariana Lopes dos Santos, 等
出版事項: (2018-11-01)

Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development
著者:: Rosalynn Molden, 等
出版事項: (2021-01-01)

Monoclonal antibodies for the therapeutic induction of tolerance.
著者:: Waldmann, H, 等
出版事項: (1993)

Therapeutic potential of monovalent monoclonal antibodies.
著者:: Cobbold, S, 等
出版事項: (1984)

The pharmacology and therapeutic applications of monoclonal antibodies
著者:: María Sofía Castelli, 等
出版事項: (2019-12-01)

Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies
著者:: E. V. Nozdrina, 等
出版事項: (2024-03-01)

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
著者:: Marisa Delgado, 等
出版事項: (2023-12-01)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
著者:: Alexander M. Horspool, 等
出版事項: (2023-04-01)

Development and Characterization of Monoclonal Antibodies for the Detection of Fish Protein
著者:: Yi-Tien Chen, 等
出版事項: (2021-10-01)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
著者:: Cobbold, S, 等
出版事項: (1984)

Therapeutic Uses of Monoclonal Antibodies for COVID-19
著者:: Tarun Kumar Suvvari
出版事項: (2020-01-01)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
著者:: Habib, O, 等
出版事項: (2019)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
著者:: Pringle, I, 等
出版事項: (2018)

DEVELOPMENT AND PROPERTIES OF NEUTRALIZING MONOCLONAL ANTIBODIES FOR FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
著者:: A. A. Kushch, 等
出版事項: (2019-04-01)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
著者:: Bindon, C, 等
出版事項: (1985)

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics
著者:: Donnellan, FR
出版事項: (2021)

Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
著者:: Alvaro Barrera-Ocampo
出版事項: (2024-07-01)

Therapeutic monoclonal antibodies with a focus on hereditary angioedema
著者:: Bruce L. Zuraw, 等
出版事項: (2023-01-01)

Monoclonal Antibodies Targeting Ion Channels and Their Therapeutic Potential
著者:: Aurélien Haustrate, 等
出版事項: (2019-06-01)

The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
著者:: Brian Kelley
出版事項: (2024-12-01)

Developing Monoclonal Antibodies for Immunohistochemistry
著者:: Jacqueline Cordell
出版事項: (2022-01-01)

Binding of omeprazole to protein targets identified by monoclonal antibodies
著者:: Naw May Pearl Cartee, 等
出版事項: (2020-01-01)

Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system
著者:: J.J. Poza Aldea
出版事項: (2012-01-01)

Impact of Urea on Monoclonal Antibodies: Multiple Destabilization and Aggregation Effects for Therapeutic Immunoglobulin G Proteins
著者:: Ji Young Yang, 等
出版事項: (2024-01-01)

Monoclonal antibody techniques. 50 years of development
著者:: Yulia S. Massino, 等
出版事項: (2024-07-01)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
著者:: Liming Liu
出版事項: (2017-04-01)

Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
著者:: C Ian Mockridge, 等
出版事項: (2022-01-01)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
著者:: Isaacs, J, 等
出版事項: (1992)

Monoclonal antibodies: a review of therapeutic applications and future prospects
著者:: Mahmuda, Aliyu, 等
出版事項: (2017)